Used as a key intermediate in the synthesis of fluorinated quinoline-based pharmaceuticals, particularly in the development of antimalarial and antibacterial agents. Its structure supports the formation of bioactive molecules that interact with pathogen DNA or enzyme targets. Also employed in research for novel kinase inhibitors due to the quinoline core’s affinity for ATP-binding sites in proteins. The fluorine and methoxy groups enhance membrane permeability and metabolic stability in drug candidates.